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Platelet Membrane Involvement
in Blood Coagulation
H.C. HEMKER, J.L.M.L. van RIJN, J. ROSING, G. van DIEIJEN,
E.M. BEVERS, and R.F.A. ZWAAL
ABSTRACT. Intact platelets do not show procoagulant phospholipids on their
exterior. These phospholipids are located at the inside leaf of the bilayer
membrane. They become available by (a) disrupture of the platelets (mechani-
calo osmotical etc.), (b) by a mechanism specific for the platelets, that we
call the membrane flip-flop.
Membrane flip-flop translocates procoagulant phospholipids (mainly phos-
phatidylserine) in the intact platelet from the inside to the outside. Thus the
intact platelet becomes procoagulant. The trigger for the flip-flop mechanism
is the simultaneous presence of small amounts of collagen and thrombin. The
clotting factors IXa and VIIIa bind to the procoagulant lipids to form the
factor X converting enzyme and factor Xa and factor Va to form prothrombin-
ase.
KEY WORDS : Thrombocyte -Membrane asymmetry -Procoagulant phos-
pholipids - Thrombin - Collagen
COFACTOR DEPENDENT REACTIONS
IN THE BLOOD COAGULATION CASCADE,
The sequence of physiological reactions that eventually leads to the forma-
tion of thrombin is known as the blood coagulation cascade. Each step
in this cascade consists of the formation of an active proteolytic enzyme
(a serine protease) from its pfo-enzyme. Several reactions in the cascade
require the presence of so-called non-enzymatic cofactors. These cofactors
are divided in two classes:
a) protein cofactors,
b) negatively charged surfaces.
It is generally known that these non-enzymatic cofactors greatly enhance
the rate of the clotting factor activation reactions in which they participate.
The reactions and their cofactors are summarized in Table 1.
A quantitative study of these reactions has become possible
a) because the proteins involved can now be obtained in a pure state
in large enough quantities and
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Table 1. Cofactor dependent reactions in blood coagulation
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Enzyme Substrate Protein cofactor Surface
Factor XII.
Kallikrein
Factor XII.
Factor VII.
Factor VII.
Factor IX.
Factor Xu
Prekallikrein
Factor XII
Factor XI
Factor IX
Factor Xl
Factor X2
Factor II
High molecular
weight
kininogen
tissue factor-
apoprotein
factor VIII
lactor V
'| 
Negatively charged
I wettable surfaces.
J sulphatides etc.
I Neeatiroetv charsed
I nhJspholipids +"Ca2 *
J 
&lood platelets).
I The extrinsic factor X activation2 The intrinsic factor X activation
Table 2. Effect of non -enzymatic cofactors on relative rates of prothrombin activation
Relative rate of prothrombin activation
Factor Xa 1
Factor Xa+Caz+ 3
Factor Xa+Caz+ +phospholipid 68
Factor Xa+Ca2+ * factor Va 560
Factor Xa + Ca2 + + phospholipid + factor Va 20,000
b) because the products of the reactions can be determined spectrophoto-
metrically with high accuracy due to the development of the so-called chro-
mogenic substrates [1].
The effects of factor Ya, Ca2* and phospholipid vesicles (containing
the negatively charged phosphatidylserine) on the rate of prothrombin acti-
vation, are shown in Table 2. Factor Va and negatively charged phospholip-
ids stimulate prothrombin activation by factor Xa independently and multi-
ply their effects. with the complete prothrombinase complex, consisting
of factor Xa, factor Ya, Ca2+ and phospholipid, a 20,000-fold rate enhance-
ment is observed. Similar observations are made for the effect of cofactors
in intrinsic and extrinsic factor X activation and the reactions of the contact
activation system.
MECHANISM OF ACTION OF NON-ENZYMATIC COFACTORS
IN PROTHROMBIN AND FACTOR X ACTIVATION
Prothrombin and intrinsic factor X activation have many features in com-
mon. The substrates in both reactions (prothrombin and factor X) are vita-
min K dependent proteins. They contain y-carboxyglutamic acid residues,
responsible for the ca2 + dependent binding to negatively charged phospho-
lipid surfaces. The enzymes (factor Xa and factor IXa), are also vitimin
K dependent proteins. The protein cofactors (factor va and factor vIIIa)
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Fig. 1. General model for the
orothrombin and factor X
activating complexes.
Phospholipid bilayers,
containing negatively
charged phospholipids,
promote the assembly of the
enzyme-cofactor-substrate
complex
Table 3. Kinetic parameters of prothrombin and factor X activation
Prothrombin activator K* prothrombin (pM) Z-.* (Ila'min- t'Xa t)
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Xa, Ca2+
Xa, Ca2+ , phospholipid
Xa, Caz+ , phospholipid, Va
84
0.06
0.21
0.68
2 . 3
1,919
Factor X activator K- factor X (pM) V^u*$.a'min-r ' IXa 1)
IXa, Caz+
lXa, Ca2 +, phospholipid
lXa, Ca2+ , phospholipid, VIIIa
1 8 1
0.06
0.063
0.01
0.002s
500
have no enzymatic activity and have a high affinity for negative phospholip-
id surfaces, although they lack /-carboxyglutamic acids. A general model
for the prothrombin and factor X activating complexes is shown in Figure 1.
Phospholipids promote the assembly of the enzyme-cofactor-substrate com-
plex (factor Xa- and factor Va- prothrombin and factor IXa- factor VIIIa-
factor X) via the above described interactions of clotting factors with the
phospholipid surface. Although it is clear that this type of enzyme complex
functions much more efficiently than the enzyme without accessory factors
(Table 2), the rate measurements do not permit conclusions about the mode
of action of the accessory factors in the erlzymatic mechanism of clotting
factor activation. Therefore we determined the effects of accessory compo-
nents on the kinetic parameters of prothrombin and intrinsic factor X activa-
tion f2, 3]. This enabled a precise quantitation of earlier observed rate
enhancements and is the frrst step in elucidating the role of accessory compo-
nents in the mechanism of coagulation factor activation. The kinetic parame-
ters of prothrombin and intrinsic factor X activation, observed for enzyme
complexes of varying composition, are summarized in Table 3. In the ab-
sence of accessory components, prothrombin and factor X activation are
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Table 4. Effect of phospholipid on K- of prothrombin for prothrombin activation and
K- offactor X for intrinsic factor X activation
Prothrombin activation Intrinsic factor X activation
Phospholipid (pM) K- app (pM) Phospholipid (pM) K- app (pM)
2.6
10 .5
26.3
52.6
75
105
240
0.032
0.068
0.164
0.25
0.35
0.48
1.08
10)o
50
75
100
150
200
300
0.058
0.139
0.363
0.409
0.525
0.822
1 .83
1 .76
In this experiment no factor Va or factor VIII" was added
very inefficient processes. The v^u* (that is the turnover number of substrate
molecules by the completely saturated enzyme) is very low and the K-
(the substrate concentration causing half maximal enzyme saturation for
prothrombin and factor X are considerably higher than the respective plas-
ma concentrations (prothrombin 2 pM, factor X 0.2 1t X[). The presence of
phospholipid plus Ca2 * causes, in both complexes, a drastic drop in the
K- to values below the plasma concentrations, while the protein cofactors
greatly increase the V^u*. The observed changes of the kinetic parameters
explain the earlier observed rate enhancements caused by accessory compo-
nents.
THE ROLE OF PHOSPHOLIPIDS
Since this paper deals with platelet membrane (phospholipid) involvement
we will not further discuss the effects of the protein cofactors, but focus
on the mode of action of the phospholipid. Both in prothrombin and intrin-
sic factor X activation, phospholipids cause a drastic drop in the K- for
prothrombin and factor X, respectively. Also the K_ is dependent on the
phospholipid concentration present in the reaction mixture (Table 4). When
the phospholipid concentration is increased, the K- increases in parallel.
So the K-, measured in the presence of phospholipid, must be an apparant
K- and is not, as such, a reaction constant of the activation under study.
A model that can explain both the drop in K^ and the apparent character
observed in the presence of phospholipid is presented in Figure 2. In free
solution, enzyme (factor Xa or factor IXa) and substrate (prothrombin
or factor X) have a low affinity for each other, which explains the high
K- measured under these conditions. When negatively charged phospholip-
ids are included in the reaction mixture, both the enzymes and substrates
Platelet Membrane Involvement in Blood Coagulation
Fig. 2. Mode of action of
phospholipids in
prothrombin and factor X
activation
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bind to the phospholipid surface via calcium bridges between their 7-carbox-
yglutamic acid residues and negatively charged head groups of phospholipid
molecules. This makes a reaction possible between phospholipid bound en-
zyme and phospholipid bound substrate and thus favours the number of
collisions between enzyme and substrate. This is the same effect as an in-
crease in concentration ofthe substrate would have. Because the real concen-
tration in the reaction vessel does not change by the addition of phospholipid
the concentration of substrate at the phospholipid surface expresses itself
as a drop in K-. Half maximal saturation of enzyme with substrate, in
the presence of phospholipid, is reached at a much lower substrate concen-
tration because it is determined by the prothrombin concentration at the
phospholipid surface. To attain the same prothrombin density at the phos-
pholipid surface at higher phospholipid concentrations, more prothrombin
is required, which explains the observed increase in the apparent K^ at
increasing phospholipid concentrations. In this model, it is expected that
although the apparent K* increases with the phospholipid concentration,
a K- expressed in terms of concentration of phospholipid bound substrate,
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Fig. 3A', B. Effect of
phospholipid concentration on
the apparent K- and the rK-
expressed in substrate surface
density for prothrombin (A)
and intrinsic factor X activation(B)
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would be constant. 9ri"q binding parameters (dissociation constant (Ko)
and concentration of_binding sites) for prothrombin and factor x bindin;
to phospholipid vesicles reported by Nelsestuen [4], we calculated the conl
centration of substrate (prothrombin and factor X) bound per pM phospho-
lipid, at_ the K-'s presented in Table 4. Figure 3 shows the meaiur"d' K-
for prothrombin and factor X activation and the amount of prothrombin
and factor X bound per pM phospholipid ar varying phosphoiipid-concen-
trations. Indeed the K- expressed in terms of phospfiolipid-bound substrate
is independent of the phospholipid concentration, whicl supports but does
not prove the proposed model.
_- 
N9t all phospholipids function equally well in prothrombin and factor
X activation. In procoagulant membranes net negaiively charged phospho-
lipids have to be present; natural phospholipids are inictive.butthermore
a liquid crystalline state of the membrane is required for maximal procoagu-
lant activity [5].
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Table 5. Phospholipid requirement of prothrombinase
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Vesicle composition (mole %) Prothrombin activation
PEPCPIPS Sph Cholesterol ('/-) (nM lla'min-r)
' .
50 30 20 2s
3 4 7 3 0 2 0 2 5
3 3 7 3 0 2 0 2 5
34
374
1.791
Intact olatelets
Platelel phospholipid extract
Platelet sonicate
z5
1,168
1 ,176
PS Phosphatidylserine, Pl Phosphatidylinositol, PC Phosphatidylcholine, PZ'Phosphati-
dylethanolamhe, Sph Sphingomyelin
Vesicle and platelet phospholipid concentration is 1 pM, prothrombin 4 pM, factor
Va 30 nM, factor Xa 15 nM
THE ROLE OF PLATELETS IN PROTHROMBIN
AND FACTOR X ACTIVATION
In vivo platelets provide the procoagulant surface required for contact
activation reactions as well as for prothrombin and intrinsic factor X activa-
tion [6, 7]. The procoagulant activity of platelets in prothrombin and factor
X activation is known as platelet factor 3. Intact non-stimulated platelets
are however inactive in clotting factor activation (Table 5). For comparison,
rates of prothrombin activation are given, obtained with vesicles composed
of the phospholipids present in the platelet membrane. When the net nega-
tively charged phospholipids (phosphatidylserine and phosphatidylinositol)
are omitted from the vesicles in which the phospholipid composition of
the platelet plasma membrane is mimicked, a low rate of prothrombin acti-
vation is measured. In contrast, artificial vesicles with a complete phospho-
lipid composition as found in platelets and also vesicles made from a
complete platelet phospholipid extract, give equally high rates of prothrom-
bin activation. Table 5 therefore shows that the net negatively charged phos-
phatidylserine is essential in producing full prothrombin activation. Phos-
phatidylserine is however almost exclusively located in the inner monolayer
of the platelet membrane [8]. It can for instance be exposed to clotting
factors in the reaction mixture if the platelets are lysed by ultrasonication
(Table 5). Lysed platelets exhibit the same prothrombin activation'-rzftes
as vesicles composed of platelet phospholipids. This suggests that only phos-
phatidylserine contributes to the enhancement of prothrombin activation
by lysed platelets. When intact platelets are stimulated with the physiological
platelet triggers, collagen or thrombin, at concentrations which give maximal
platelet aggregation and serotonin release, small rate enhancements are mea-
sured in assay systems for prothrombin and intrinsic factor X activation
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Table 6. Effect of platelets in prothrombin and intrinsic factor X activation
Platelets timulated by: Prothrombin activation
(nM lla'min 1)
Factor X activation
(nM X"'min 1)
Thrombin (1.3 nM)
Collagen (10 g/ml)
Thrombin (1.3 nM)
plus collagen (10 g/ml)
Concentrations:
3 ) Z
4 pM prothrombin, 15
bin activation 0.5 pM
factor X activation
34
40
98
L . J
3 . 1
18 .6
47.3
nM Xa ,30
X, 150 nM
nM Va for prothrom-
IXa. 15 nM VIIIa for
Table 7. Sites for prothrombin and factor X activation on human platelet membranes
Platelet stimulator Prothrombin activation
(sites/platelet)
Factor X activation
(sites/platelet)
Thrombin
Thrombin * collagen
? 50n
3,000
26,000
900
1,200
19,000
(Table 6). The increase of both activities can be explained by the small
amount of platelet lysis brought about by the admixture of the reagents.
Thrombin plus collagen will not cause more lysis than each reagent alone.
When compared with unstimulated platelets, platelets triggered by the com-
bined action of collagen plus thrombin however show a tenfold increase
of activity in prothrombin activation, and a 20-fold rate enhancement in
factor X activation. Bevers et al. [8] found that platelets, which were trig-
gered by the combined action of collagen plus thrombin, exposed their
internally Tocalized phosphatidylserine to the membrane exterior. This intro-
duction of phosphatidylserine in the outer monolayer of the platelet mem-
brane produces a platelet surface which promotes the assembly of both
the prothrombin and intrinsic factor X activating complex by binding of
vitamin K dependent clotting factors. This explains the observed rate en-
hancement of thrombin plus collagen stimulated platelets in prothrombin
and factor X activation (Table 6). Experiments as presented in Table 6 can
be used to quantitate the number of prothrombin and factor X activating
complexes on the platelet surface. In order to do this, the coagulation factors
were added in saturating amounts so as to occupy all functional sites on
the platelets surface and moreover to measure under Z-u* conditions. Z-u*
values obtained with phospholipid vesicles as a procoagulant surface
(2,700 min for prothrombin and 500 min for factor X activation) are used
in these calculations. The amounts of calculated sites (Table 7) for unstimu-
lated and thrombin activated platelets are relativelv low as compared with
Platelet Membrane Involvement in Blood Coagulation J l l
Fig. 4. Time course of
appearance of platelet activity
in prothrombin and factor X
activation. Coagulation factor
concentrations : for prothrombin
activation, 4 pM prothrombin,
15 nM factor Xa, 30 nM Factor
Va, for factor X activation,
0.5 pM factor X, 50 nM factor
IXa and 0.1 nM factor VIIIa.
100% activity in prothrombin
activation is 800 nM'min- I. IIa
formed, l00o/o activity in factor
X activation is 17 nM'min- 1
factor Xa formed. Platelets were
stimulated with thrombin plus
collasen
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MINUTES AFTER PLATELET ACTIVATION
platelets stimulated by collagen plus thrombin together. It is not clear wheth-
er unstimulated platelets, under physiological circumstances, indeed have
this low but signifrcant amount of functional binding sites or that they
are partially activated. Also a part of this activity must be attributed to
the inevitable lysis that occurs during platelet isolation procedures. For
the collagen plus thrombin stimulated platelet, approximately 26,000 func-
tional binding sites for the prothrombinase complex and approximately
20,000 for the factor X activating complex have been calculated. These
numbers are so close to each other that they strongly suggest hat at saturat-
ing coagulation factor concentrations, the same sites function in prothrom-
bin and factor X activation at the surface of stimulated platelets. This obser-
vation suggests that the essential component for both the binding of the
proteins of the prothrombin and the intrinsic factor X activating complexes
is the phosphatidylserine, that after platelet triggering becomes exposed in
the outer monolayer of the membrane.
The time course of the appearance of procoagulant activity in stimulated
platelets can be followed in the assay systems for prothrombin and intrinsic
factor X activation. In Figure 4 the generation of a procoagulant surface
is followed at saturating factor X4 Ya and prothrombin concentrations
in the prothrombin activating assay, and at sub-saturating factor IXa and
VIIIa concentrations in the factor X activating system. Half maximal factor
X converting activity is observed within 2 min after addition of collagen
plus thrombin, whereas prothrombin converting activity reaches the half
maximal value after 9 min. The observed differences between the time
courses seem to contradict the idea that the essential component of the
procoagulant surface of stimulated platelets is exclusively phosphatidylser-
ine. This difference can be explained however without postulating other
procoagulant components.
The requirement of procoagulant phospholipid as a component of the
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Fig. 5. Effect of phospholipase
A, on the activity of collagen
plus thrombin stimulated
platelets in prothrombin and
factor X activation.
Coagulation factor
concentrations were as
described in Fig.4. Stimulated
platelets were either treated
(closed symbols) or not (open
symbols) with phospholipase Ar.
The triangles represent
prothrombin activation, the
circles factor X activation
be 60
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functional sites for the prothrombin and factor X activating complexes could
be determined in phospholipase digestion experiments. Platelets are stimu-
lated with collagen plus thrombin until maximal procoagulant activity is
reached and subsequently treated with Naja naja phospholipase 42, an en-
zyme known to degrade phospholipid molecules exposed at the outer platelet
surface [7]. Using high phospholipase A, concentrations, both prothrombin
and intrinsic factor X converting activities of the stimulated platelets are
completely abolished within 10 min. The absence of leakage of lactate dehy-
drogenase from the platelets during incubation with the phospholipase, indi-
cates that the platelet membrane remains intact. So the conclusion can
be drawn that procoagulant phospholipids are an essential component in
the functional sites for prothrombin and factor X activation on the stimu-
lated platelet. When small amounts of phospholipase A2 are used, the time
course of decay of prothrombin and factor X converting activity of the
stimulated platelets could be followed. After different time intervals of phos-
pholipase treatment, the coagulation factors are added to measure the re-
maining procoagulant activity. Figure 5 shows that the factor X converting
activity of platelets is more sensitive to phospholipase treatment than the
platelet prothrombin converting activity. It was investigated whether the
differences in time course of generation of a procoagulant platelet surface
and the sensitivity to phospholipase A, treatment, as estimated with pro-
thrombin and factor X activation, could be related to different phospholipid
requirements. Therefore, prothrombin and factor X activation are measured
in model systems, using phospholipid vesicles with varying phospholipid
composition. Prothrombin and factor X converting activities are measured,
using the same coagulation factor concentrations as in the experiments with
platelets. The vesicles are composed of lipids at the same molar concentra-
tion as found in platelet membranes, with the exception of phosphatidylser-
ine and phosphatidylcholine. The mole fraction phosphatidylserine is varied
Platelet Membrane Involvement in Blood Coagulation
Fig. 6. The effect of
phospholipid vesicles with i
varying mole percentage :
phosphatidylserine in H
prothrombin (closed symbols) G
and factor X activation (open .E
symbols).100% activity in E
prothrombin activation is 2,900 ;
nM.min 1,1000 activity rn Be
factor X activation is 71.5 nM'
mln ^
phosphat idy lser ine  (  mo le% )
at the expense of phosphatidylcholine and the overall phospholipid concen-
tration is kept at 2 pM. The rates, given as percentage of the maximal
activity, measuled for prothrombin and factor X activation at varying mole
percentage phosphatidylserine, are given in Figure 6. Larye differences in
phosphatidylserine fequirement for prothrombin activation and factor X
ictivation are observed. For the intrinsic factor X activation, a mole fraction
of 20oh phosphatidylserine is required for maximal activity, whereas for
prothrombin activation 2.5o/o phosphatidylserine is optimal. At a surface
containing less than 2.5% phosphatidylserine, factor X activation rates are
negligible, while prothrombin activation still proceeds at a considerable rate.
This phenomenon provides the explanation for the observed differences
in phospholipase sensitivity of stimulated platelets in prothrombin and fac-
tor X activation. If phosphatidylserine in the outer membrane is degraded
by phospholipase Ar, such that the mole fraction phosphatidylserine in
the membrane becomes less than 2.5oA, still a considerable rate of prothrom-
bin activation can be measured, whereas factor X activation is almost com-
pletely abolished.
Platelets stimulated with collagen plus thrombin expose 25o/o of theit
phosphatidylserine at the platelet outer surface [8], it can be calculated
that the overall mole fraction phosphatidylserine in the outer monolayer
of the platelet is at most 5%. A model phospholipid vesicle containing
5 mole % phosphatidylserine would show a ratio of the rates of prothrombin
activation and factor X activation of 200: 1. Platelets stimulated fot 2 min
with thrombin plus collagen give a rate latio of 15 : 1. So the phosphatidylser-
ine exposed at the outer surface of the collagen plus thrombin stimulated
platelet, cannot be randomly distributed in the outer monolayer of the plate-
let membrane. Domains with higher mole pelcentage phosphatidylserine
must exist in the outer monolayer of the platelet membrane after stimulation
with collagen plus thrombin. Otherwise the observed ratio of prothrombin
and factor X activation rates cannot be explained. Most of these phosphati-
dylserine enriched domains are formed within 3 min after platelet stimula-
tion, as can be concluded from the time course of generating factor X
J I J
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Fig. 7. Model for the
generation of a platelet
procoagulant surface.
Phosphatidylserine molecules
are indicated by closed dots
converting activity. After 3 min platelet stimulation, most of the procoagu-
lant surface for prothrombin activation has still to be made (Fig. a). Based
on these observations, we propose that the phosphatidylserine, exposed at
the surface of collagen plus thrombin stimulated platelets, is not homogen-
eously distributed in the outer monolayer of the platelet membrane. Do-
mains with high phosphatidylserine density, which rapidly appear at the
surface of stimulated platelets, are measured predominantly with the factor
X activating system and to a minor extend with the prothrombin activating
system. Domains with low phosphatidylserine, which appear slower, can
only be measured by the prothrombin activating system. If these lateilal
phase separations in the outer monolayer of the membrane occur during
platelet activation, other components may be required to induce or maintain
them. In Figure 7a model is proposed, in which after triggering with corlagen
plus thrombin the first phosphatidylserine molecules that appear at the
platelet surface, are clustered by membrane proteins. The progressive trans-
bilayer movement after prolonged activation saturates the clustering pro-
teins with phosphatidylserine. Phosphatidylserine molecules appearing
thereafter are diluted over the platelet membrane, so forming a domain
with low phosphatidylserine density favourable for factor II activation.
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Discussion
Discussion
OBRINK: You have shown that there is an increase in phosphatidylserine
on the outside of the platelets during activation. Do you know if that is
a function of flip-flop or if it is insertion of new membrane into the plasma
membrane? It could be membrane vesicles inside the cells which fuse with
the plasma membrane.
HEMKER: We think it's flip-flop, because for the phosphatidylserine that
appears outside, phosphatidylcholine disappears at the same time. That's
one thing. The other thing is that it can, of course, be explained by diffusion
of vesicles with the outer surface of the platelet. But as far as I've been
told, the asymmetry of the vesicles in the platelets is just the other way
round from the asymmetry of the membrane of the platelet itself. So if
this is the outer membrane and this is the vesicle, then the phosphatidylserine
will be at the inside of the outer membrane and at the outside of the vesicle.
So upon fusion, you will have the same situation as if there were no flip-flop.
This of course is what we also frnd, because we don't hnd phosphatidylserine
at the outside if we trigger the platelets with thrombin, in which case there
is fusion.
FROJMOVIC: Two small points. One is that Neville CRawlonl has been
publishing papers on sonication of platelets to essentially try to fractionate
membranes, and they hypothese that they may be separating surface con-
necting system from the surface itself, and that is showing very distinct
biochemical properties. I just leave this to you as a possible thought, that
instead of flip-flop, perhaps you could have exchange form the surface
connecting system to the membrane which is being induced. Can you rule
that out? Part B, is there a flop-flip?
HEMKER: I'm not quite sure that I got the gist of your first question.
As far as we know, we have no reason to assume that the surface connecting
system has a different phospholipid composition than the overall membrane.
Secondly, indeed there is flop-flip.
CAEN: You mentioned no effect whatsoever when using indomethacin.
Have you tried the collagen-thrombin interaction with some compound
which may affect calcium and even phosphatidic acid?
HEMKER: No, we didn't try.
NURDEN: Let me see if I remember correctly. Both Ken MaNN and Dr
Mlrsnus were proposing that there was a protease activity in platelets that
may be responsible for at least some transformation of Factor V into Factor
V-a, and it was hypothesized this might be the calcium-dependent protease.
Now, one possible explanation for the defrcit of glycoprotein I and V and
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the 17,000 glycoprotein in these platelets is that there is an abnormal, at
least focal, protease activity in Bernard-Soulier megakaryocytes or platelets.
It could be this protease. It would therefore be very interesting to look
at the Factor V in the platelets and its release from Bernard-Soulier platelets
to see if there's any abnormality there.
HEMKER: That was precisely the reason why yesterday I asked if you
know anything about the release of Factor V in Bernard-Soulier platelets.
SOULIER: May I ask you something, Dr. HsN{KEn? In 1975 Wnrsrr said
that in Bernard-Soulier syndrome there was no collagen activation at the
platelet level. Perhaps collagen and thrombin are inadequate when there
is a lack GPI. But he also said that there was no Factor XI at all on
the platelet, and when mentioning other proteins, you didn't make any
allusion to that. What is your opinion about that?
HEMKER: In fact, we have been doing these experiments with purified
coagulation factors, and we don't have any purified Factor XI around,
so that's the reason I didn't study it.
MILTON: Presumably the reason why an asymmetry of lipids exists in
the membrane is that there is an energy barrier there that stops the lipids
going across to other side. I want to know if that energy barrier is a function
of the conformation of the membrane. I'm just wondering if you completely
change the conformation of the membrane, it may be preferable for the
membrane lipids to come back over, just from the energy point of view.
HEMKER: A membrane that is symmetrical is a more likely one than
one that is asymmetrical. I keep asking membrane biochemists, what is
the source of the asymmetry? I get all kinds of answers, but not very strict
ones up to this moment. It might well be, it's very probable indeed, that
there is an interaction between the inside of the membrane and the proteins
that are described just lying against the inside of the membrane. We see
all kinds of reactions in activated platelets, and among them might be this
interaction between internal proteins and membrane disruption, followed
specifically by phosphatidylserine externalization. But on the other hand,
that wouldn't explain why it's a reversible process.
WHITE: In that respect, certainly there are changes in the submembrane
area and submembrane proteins. But the interesting aspect of that is in
fact, they're quite reversible. We've done a number of studies on activating
platelets usually by aggregating them with ADP and taking apart the aggre-
gated platelets with something like prostacyclin, and then, those platelets
completely recover their shape, but they're refractory. As soon as you disso-
ciate the platelets, the phosphorylation will disappear, and if you activate
them again, it'll redevelop along with the now triton resistant cores, and
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then I would suspect that the cycling of those proteins and protein events
will correlate with the flip-flop or flop-flip of the membrane.
HEMKER: I think that's a distinct possibility, and I would just like to
suggest that if you do this type of experiment again, you should not only
try collagen and thrombin but also a combination of the two, and whenever
you come across situations in which the combination of the two does some-
thing which is absolutely different from one of the two alone, then you
are very probably in the region where the phenomena you observe have
something to do with the flip-flop.
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